Novo Nordisk Clinical Trial Call Center

Princeton, New Jersey 08540

0 studies enrolling now · 6 studies all time

What they study most

Acquired Bleeding Disorder, Congenital Bleeding Disorder, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glanzmann's Disease, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors, Trauma

Studies at this site

• A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors — Completed
• INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study — Completed
• Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants — Completed
• An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes — Completed
• Observational Registry of the Treatment of Glanzmann's Thrombasthenia — Completed
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding — Stopped early